MétaCan
Menu
← Back to cohort
Record W7135918300

Developmental dysregulation of the cortical reelin signalling pathway precedes adolescent cognitive deficits in a neurodevelopmental model for schizophrenia

2023· article· en· W7135918300 on OpenAlexfundno aff
Rebecca; id_orcid 0000-0002-8413-4852 Woods

Bibliographic record

VenueResearch Explorer (The University of Manchester) · 2023
Typearticle
Languageen
FieldNeuroscience
TopicNeurogenesis and neuroplasticity mechanisms
Canadian institutionsnot available
FundersNIHR Cambridge Biomedical Research CentreNIHR Imperial Biomedical Research CentreNational Institute of Mental HealthScience and Technology Facilities CouncilEngineering and Physical Sciences Research CouncilInstitute of Psychiatry, Psychology and Neuroscience, King’s College LondonH. Lundbeck A/SUniversidade Federal do Rio Grande do SulKrembil FoundationU.S. Public Health ServiceHospital de Clínicas de Porto AlegreNederlandse Organisatie voor Wetenschappelijk OnderzoekAXA Research FundImperial College Healthcare NHS TrustWellcome TrustUniversity College LondonGeorge Washington UniversityKing's College LondonMedical Research CouncilIsrael Cancer Research FundDepartment of Health and Social CareNational Institute for Health and Care ResearchInstituto D'Or de Pesquisa e EnsinoRoyal Holloway, University of LondonInternational Max Planck Research School for Environmental, Cellular and Molecular MicrobiologyRosetrees TrustResearch for Patient Benefit ProgrammeNational Alliance for Research on Schizophrenia and DepressionNIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer ResearchSouth London and Maudsley NHS Foundation TrustDirectorate for Biological SciencesImperial College LondonGlaxoSmithKlineMenzies Centre for Australian Studies, King's College London, University of LondonSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungJacobs FoundationDell EMCLeverhulme TrustFoundation for Excellence in Mental Health CareUniversity College London Hospitals NHS Foundation TrustJohns Hopkins UniversityPfizerNational Science Foundation
KeywordsSchizophrenia (object-oriented programming)CognitionReelinSignallingNeurodevelopmental disorderPsychosis
DOInot available

Abstract

fetched live from OpenAlex

Ketamine is a very cheap, potent, drug with proven potent antidepressant action in patients with otherwise treatment resistant depression.It causes acute dissociative symptoms when administered parenterally.As a generic, legal, 'non-natural' drug which has addiction potential and does not hit the salience network, advocacy for its use has been less vociferous than for 5HT2a psychedelics.Oxford Health NH Trust's Interventional Psychiatry Service grew out its ECT service and now administers IV ketamine 5 days a week in private (3 days) and NHS (2 days) streams to 9 patients daily.The presence of anaesthetists for the ECT service facilitated the transition to a psychiatrist led ketamine service.Staffing is typically a doctor, a nurse and a healthcare assistant, with a minimum of a doctor and an HCA.Safe, long-term administration is possible but, given the chronic/episodic nature of depression, it is not surprising that repeated administration is needed to maintain the benefit.Relapse does, of course, sometimes occur despite continued use: the social losses in chronic depression are powerful maintaining factors.However, the tolerance which sometimes develops is usually manageable with dose and frequency adjustment.Chronic depression is often complicated by changes in patterns of relationships; unlearning these take time.Two recent phase 3 RCTs suggest that ketamine causes fewer long term side effects than, and may be as effective as ECT particularly in those under 50 (Ekstrand et al 2022; Anand et al 2023).In both studies, effect sizes are affected by differential dropout.A third large pragmatic long term study is underway (NCT03674671).Post-Brexit, the MHRA, NICE and NHS have developed a new mechanism for repurposing drugs (https://www.england.nhs.uk/medicines-2/medicines-repurposing-programme/).IV racemic ketamine, at a dose of 0.5mg/kg, would be a strong candidate for licensure under this scheme.It is likely to be cost-effective as an alternative to ECT in the NHS.Routine administration of IV ketamine in the NHS is feasible using the existing ECT services, though it is likely that such services would need to expand.Experience with ketamine will also help the NHS develop the infrastructure, processes and safeguards necessary for the acceptance into NHS practice of other psychedelics.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.189
GPT teacher head0.302
Teacher spread0.113 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractno

Explore more

Same venueResearch Explorer (The University of Manchester)→Same topicNeurogenesis and neuroplasticity mechanisms→French-language works237,207→